Registering for Training and Certification

  1. You have to register for the Certified Methadone Advocate Training course
    through NAMA. The training course is one day. The first training will be at
    the AATOD Conference in Washington on Saturday April 12, 2003. The cost of
    course is $100 and includes 2003 membership in NAMA. Everyone who
    pre-registers and completes the requirements will receive their Patient
    Advocate Training Certificate on the day of the conference. Advocate’s will
    receive their NAMA CPA certification in the
    mail.
  2. Registration for the conference is separate. Contact :American Association for the Treatment
    of Opioid Dependence
    . Unless you need a scholarship then NAMA will
    register you.
  3.  A limited number of scholarships to attend the AATOD conference

    (conference registration and hotel) will be available for advocates 
    through this committee, however you must pay for the Certified
    Methadone Advocate training to qualify. Scholarships for CMA Training itself
    are only available in cases of unusual financial need.

  4. Scholarships are no longer available except for unusual circumstances
    directly through NAMA.
  5. Don’t forget if you want to take the training you have to download a copy
    of the registration form and mail it to NAMA with $100 or or call 212-6979534
    to arrange credit card payment.

    Download
    registration in .pdf
     
        Download registration
    as Word .doc
      
             

    Return to Index

Similar Posts

  • Focus On

    Admin 02/26/2023

    Issues To Focus On Massachusetts Restores Methadone Funding Highlights from a compromise budget plan unveiled by House and Senate leaders on Thursday The $22.3 billion plan would: Restore Medicaid funding for 36,000 people under MassHealth Basic; Preserve a popular prescription drug coverage program for the elderly; Repeal the voter-approved Clean Elections law; Tighten the Quinn…

  • |

    Basic Information About Buprenorphine

    Admin 04/20/2023

    Basic Information About DATA On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of schedule III, IV or V opioid treatment drugs that are approved by the FDA for maintenance or detoxification treatment. Summary of Title XXXV NIDA/SAMHSA Announcement & Press Release NIDA Research and…

  • Policy Statements

    Admin 11/02/2021

    Policy Statement 1 Methadone Medical Maintenance April 1994 Download File  (pdf format) Policy Statement 2 The Policy of Blind Dosing and Patient Dignity April 18, 1994 Download File (pdf format) Policy Statement 3 Discharge From Treatment for Drug Use May 1994 Download File (pdf format) Policy Statement 4 Patient vs Client May 1994 Download File (pdf format) Policy…

  • Past Present and Future: A Selection of Unfinished Business in Methadone Treatment

    Admin 11/21/2021

    NAMA at National Methadone Conference – AMTA 2001 Wednesday, October 10th Moderator, Howard Lotsof, NAMA Acting Membership Director Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President). The Patients’ Perspectives on the Changes in the Methadone Treatment System. Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President). Tapering – The Last Ten Milligrams. Jo…

  • Workshop Wednesday, October 10th

    Admin 11/25/2021

    Workshop Wednesday, October 10th Past Present and Future: A Selection of Unfinished Business in Methadone Treatment Moderator, Howard Lotsof, NAMA Acting Membership Director Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President). The Patients’ Perspectives on the Changes in the Methadone Treatment System. Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President). Tapering –…

  • In Memory of John Mordaunt

    Admin 09/11/2022

    John Mordaunt was a tireless advocate of HIV infected drug users. He was the first HIV+ drug user to be shown on national television in his country, England. Mordaunt helped to found the British advocacy organization for HIV infected drug users called Frontliners and was active with the European Interest Group on Drug Policy, a…